Yunus Kara

Yunus Kara

Auto-generated profile, based on publicly available information

Yunus Kara

Department of Chemistry, Faculty of Sciences, Ataturk University, Erzurum, Turkey

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 January 2017 in Medicinal Chemistry Research
Verified
Journal Article
Closed access
PDF file
AKAytekin Köse
Aytekin Köse
YBYıldız Bal
Yıldız Bal
NKNurhan H. Kishalı
Nurhan H. Kishalı
GŞGülşah Şanlı-Mohamed
Gülşah Şanlı-Mohamed
YKYunus Kara
Yunus Kara

1 January 2020 in Bioorganic Chemistry
Verified
Journal Article
Closed access
AKAytekin Köse
Aytekin Köse
MKMeltem Kaya
Meltem Kaya
NKNurhan H. Kishalı
Nurhan H. Kishalı
AAAtilla Akdemir
Atilla Akdemir
EŞErtan Şahin
Ertan Şahin
GŞGülşah Şanlı-Mohamed
Gülşah Şanlı-Mohamed

22 August 2014 in Helvetica Chimica Acta
Verified
Journal Article
Closed access
PDF file
ATAyse Tan
Ayse Tan
EBEbru Bozkurt
Ebru Bozkurt
NKNurhan Kishali
Nurhan Kishali
YKYunus Kara
Yunus Kara

4 February 2012 in Tetrahedron
Verified
Journal Article
Closed access
MFMeryem Fistikci
Meryem Fistikci
OGOzlem Gundogdu
Ozlem Gundogdu
DADerya Aktas
Derya Aktas
HSHasan Secen
Hasan Secen
MSM. Fethi Sahin
M. Fethi Sahin
YKYunus Kara
Yunus Kara

8 July 2020 in Anti-Cancer Agents in Medicinal Chemistry
Verified
Journal Article
Closed access
PDF file
ATAyse Tan
Ayse Tan
SKSerap Kizilkaya
Serap Kizilkaya
UKUnzile Kelestemur
Unzile Kelestemur
AAAtilla Akdemir
Atilla Akdemir
YKYunus Kara
Yunus Kara
Background: Isoindole-1,3(2H)-dione derivatives are known to have cytotoxic effects on many cancer cells. The anticancer activity of these compounds varies depending on the substituents attached to them. Therefore, the effect of substituents is very important when determining the anticancer activities of molecules. We have recently reported an example of the substituent effect. : According to that work, the anticancer activity against HeLa, C6, and A549 cancer cell lines of isoindole- 1,3(2H)-dione compounds containing tert-butyldiphenylsilyl ether, azido, and hydroxyl groups was examined by our group. It was found that an isoindole-1,3(2H)-dione compound containing both tert-butyldiphenylsilyl ether group and azido groups showed higher anticancer activity than 5-fluorouracil and another isoindole-1,3(2H)- dione compound containing both azido and hydroxyl groups. : After we discovered that tert-butyldiphenylsilyl ether group in the skeletal structure of isoindole-1,3(2H)-dione exhibits anticancer activity against HeLa, C6, and A549 cancer cell lines, we wanted to examine the anticancer activities of different silyl ether groups, i.e., OTMS, -OTBDPS, and -OTBDMS groups, and also -OH and -Br groups, by comparing them with each other according to the structure–activity relationship. Methods: All of the synthesized compounds were characterized by 1H and 13C NMR spectra, IR spectroscopy, and mass spectra measurements. The IC50 values of these compounds were calculated for all cancer cell lines and compared with each other and cisplatin, which is a platinum-containing chemotherapeutic drug. Molecular modelling studies were carried out using the MOE software package. Results: It was found that compounds 13 and 16, containing both silyl ether (-OTBDMS) and -Br groups, showed higher anticancer activity than cisplatin against both Caco-2 and MCF-7 cell lines. Compounds 20 and 23 showed anticancer activity in MCF-7 cells and compounds 8, 9, 20, and 23 in Caco-2 cells. While compounds 20 and 23 have only a silyl ether (-OTMS) group, compounds 8 and 9 have only a -OH group. Molecular modelling studies indicated that compounds 8 and 13, as well as their analogs, may bind to the active site of hRS6KB1 (pdb: 4l3j), compound 11 may bind to the active site of human mTOR (pdb: 4jt5) and additionally, compounds 10-17 are expected to be both mutagenic and reactive according to the mutagenicity and reactivity calculations. Conclusion: According to these results, the anticancer activities of isoindole-1,3(2H)-dione compounds (8 - 23) vary depending on the groups they contain and these groups affect each other's activities. Silyl ethers (-OTBDMS and -OTMS) and -OH and -Br groups in the skeletal structure of isoindole-1,3(2H)-dione can be regarded as anticancer agents. In this sense, compounds 13 and 16, containing both silyl ether (-OTBDMS) and - Br groups, may be regarded as alternative chemotherapeutic drugs. This work may lead to the synthesis of new isoindole-1,3(2H)-dione compounds containing different silyl ether groups and studies evaluating their anticancer activities or other biological properties.

7 March 2022 in Journal of Biochemical and Molecular Toxicology
Verified
Journal Article
Closed access
ATAyse Tan
Ayse Tan
SKSerap Kizilkaya
Serap Kizilkaya
SNSamir A. A. Noma
Samir A. A. Noma
BABurhan Ates
Burhan Ates
YKYunus Kara
Yunus Kara